Approach to the Patient with Possible Cardiovascular Disease¶

Chapter 243 | Part 6: Disorders of the Cardiovascular System · Part 6 – Cardiovascular Disorders · Chapter 243

Key Clinical Points¶

Cardiovascular diseases are the leading cause of death for both men and women, with approximately one-third of these deaths occurring suddenly.
Cardiac symptoms (dyspnea, chest discomfort, edema, syncope) often share non-cardiac mimics; careful clinical examination is required to differentiate them.
Symptoms appearing during activity are characteristic of heart disease; symptoms at rest remitting during exertion are rarely observed in cardiac patients.
A complete cardiac diagnosis requires four components: 1. Underlying etiology, 2. Anatomic abnormalities, 3. Physiologic disturbances, and 4. Functional disability (NYHA classification).
The NYHA classification categorizes functional disability based on the level of physical activity required to elicit symptoms.
Heart murmurs must be evaluated by timing, duration, intensity, quality, frequency, configuration, location, and radiation.
Gender differences exist: women more frequently have coronary artery disease associated with microcirculation dysfunction; exercise ECG has lower accuracy in predicting epicardial obstruction in women.
Risk factors like obesity, type 2 diabetes, and metabolic syndrome are increasingly impacting cardiovascular outcomes globally.
Genetic testing identifies monogenic conditions (e.g., hypertrophic cardiomyopathy, Marfan's syndrome, prolonged QT syndrome) or polygenic risks (e.g., hyperlipidemia).
The severity of a patient's functional disability should dictate the urgency and extent of the diagnostic workup.

DEFINITION & OVERVIEW¶

• Prevalence: Cardiovascular diseases are the most prevalent serious disorders in industrialized nations and are a rapidly increasing problem in developing nations. • Mortality: They are the leading cause of death for both men and women. In the United States, they account for nearly 700,000 deaths annually; approximately one-third of these are sudden. • Global Impact: Approximately 19 million deaths worldwide are attributed to cardiovascular diseases. • Clinical Scope: A complete cardiac diagnosis requires a comprehensive assessment including: ◦ Underlying etiology (e.g., congenital, hypertensive, ischemic, or inflammatory). ◦ Anatomic abnormalities (chamber size, valve status, pericardial involvement, myocardial infarction history). ◦ Physiologic disturbances (arrhythmia, heart failure, ischemia). ◦ Functional disability (quantified by the NYHA classification).

EPIDEMIOLOGY¶

• Trends: While age-adjusted death rates for coronary heart disease have declined by two-thirds in the US over four decades, absolute numbers of deaths in women have actually risen. • Risk Factors: The growing prevalence of obesity, type 2 diabetes mellitus, and metabolic syndrome threatens to reverse progress in reducing mortality from coronary heart disease. • Gender Differences: ◦ Cardiovascular disease is the leading cause of death for both men and women. ◦ Inflammation, obesity, type 2 diabetes, and metabolic syndrome play more prominent roles in coronary atherosclerosis in women than in men. ◦ Coronary artery disease (CAD) is more frequently associated with dysfunction of the coronary microcirculation in women than in men. ◦ Exercise electrocardiography has a lower diagnostic accuracy in predicting epicardial obstruction in women than in men.

ETIOLOGY & PATHOPHYSIOLOGY¶

• Symptom Mechanisms: Symptoms result from: ◦ Myocardial ischemia: Imbalance between heart's oxygen supply and demand → manifests most frequently as chest discomfort. ◦ Disturbance of contraction/relaxation: Leads to fatigue and elevated intravascular pressure → results in abnormal fluid accumulation (peripheral edema or pulmonary congestion/dyspnea). ◦ Obstruction to blood flow: Occurs in valvular stenosis; causes symptoms resembling myocardial failure. ◦ Abnormal cardiac rhythm or rate: Often develop suddenly; symptoms include palpitations, dyspnea, hypotension, and syncope.

CLINICAL FEATURES¶

• Cardinal Manifestations: Dyspnea, chest discomfort, edema, and syncope. • Exertion Correlation: ◦ Symptoms appearing during activity are characteristic of heart disease. ◦ Symptoms at rest remitting during exertion are rarely observed in cardiac patients. • Asymptomatic Presentation: Many patients may be asymptomatic both at rest and during exertion but may present with abnormal physical findings (heart murmur, elevated arterial pressure) or abnormalities on ECG/imaging.

Symptom Specifics¶

• Chest discomfort: Most frequently caused by myocardial ischemia. • Fatigue: Commonly results from reduced pumping ability. • Edema: Results from elevated intravascular pressure upstream of the failing ventricle; leads to peripheral edema or pulmonary congestion and dyspnea. • Palpitations: Associated with cardiac arrhythmias. • Syncope: Associated with serious cardiac arrhythmias or neurologic conditions.

DIFFERENTIAL DIAGNOSIS¶

• Non-Cardiac Mimics: ◦ Dyspnea: Pulmonary disease, marked obesity, and anxiety. ◦ Edema: Primary renal disease and hepatic cirrhosis. ◦ Syncope: Various neurologic conditions. • Diagnostic Strategy: Differentiation is achieved through careful clinical examination supplemented by noninvasive testing (ECG, exercise testing, echocardiography, and cardiopulmonary imaging).

INVESTIGATIONS & DIAGNOSIS¶

• Clinical Foundation: Diagnosis begins with history and physical examination. • Laboratory & Imaging Suite: ◦ ECG: Used for arrhythmias, conduction abnormalities, ventricular hypertrophy, and acute myocardial infarction (does not generally establish specific diagnosis otherwise). ◦ Noninvasive Imaging: Chest x-ray, echocardiogram, radionuclide imaging, CT, PET, and MRI. ◦ Blood Tests: Lipid determinations, C-reactive protein (risk assessment), and brain natriuretic peptide (BNP) for cardiac function. ◦ Invasive Exams: Cardiac catheterization and coronary arteriography. ◦ Genetic Tests: Identify monogenic diseases (hypertrophic cardiomyopathy, Marfan's syndrome, prolonged QT interval). • Family History Assessment: ◦ Mendelian Transmission: Hypertrophic cardiomyopathy, Marfan's syndrome, and sudden death associated with a prolonged QT syndrome. ◦ Polygenic Disorders: Premature coronary disease, essential hypertension, type 2 diabetes mellitus, and hyperlipidemia (most important risk factors for CAD). ◦ Behavioral Factors: Identify shared dietary/behavioral patterns (e.g., high salt/calorie intake, smoking). • Functional Assessment: Determine the level of activity and rate required to elicit symptoms (e.g., distance walked, stairs climbed) to determine severity. ◦ Note: The presence of edema or breathlessness in a patient receiving optimal doses of diuretics is more grave than in an untreated patient.

NYHA Classification Table¶

Table 243-1 summarizes the NYHA Functional Classification: • Class I: No limitation of physical activity; No symptoms with ordinary exertion. • Class II: Slight limitation of physical activity; Ordinary activity causes symptoms. • Class III: Marked limitation of physical activity; Less than ordinary activity causes symptoms; Asymptomatic at rest. • Class IV: Inability to carry out any physical activity without discomfort; Symptoms at rest.

Murmur Evaluation Flowchart¶

The following logic determines the required workup for a heart murmur: 1. Identify Murmur Type: ◦ Diastolic or Continuous → Echocardiography. 2. Evaluate Systolic Murmurs: ◦ If Grade III or >, holosystolic, or late systolic → Echocardiography. ◦ If Grade I + II and midsystolic → Proceed to Step 3. 3. Assess Clinical Context (for Grade I+II Midsystolic): ◦ If other signs/symptoms of cardiac disease present → Echocardiography. ◦ If abnormal ECG or chest x-ray → Echocardiography. ◦ If asymptomatic, no associated findings, and normal ECG/chest x-ray → No further workup.

MANAGEMENT & TREATMENT¶

• Step 1: Risk Assessment: Assess global risk of CAD in asymptomatic individuals using clinical assessment, lipid panels, and biomarkers (e.g., C-reactive protein). • Step 2: Clinical Diagnosis Components: ◦ Identify specific etiology (ischemic, congenital, hypertensive, inflammatory). ◦ Identify anatomic abnormalities (chamber size, valve status, pericardial involvement). ◦ Identify physiologic disturbances (arrhythmia, heart failure, ischemia). • Step 3: Treatment Strategy Considerations: ◦ Severity of disability determines the extent and tempo of workup. ◦ Severity of disability influences the selected therapeutic strategy. ◦ Assess for complicating factors (e.g., anemia, thyrotoxicosis, or supraventricular tachycardia). • Step 4: Prevention & Early Intervention: Identify high-risk patients (e.g., those with known risk factors for atherosclerosis or family history of cardiomyopathy) to initiate early intervention before acute events occur.

PROGNOSIS & COMPLICATIONS¶

• Acute Complications: Sudden cardiac death, acute myocardial infarction, stroke in previously asymptomatic individuals. • Chronic Complications: Gradually increasing dyspnea, other manifestations of chronic heart failure, and episodes of acute deterioration late in the disease course.

SPECIAL CONSIDERATIONS¶

• Gender Differences: ◦ Prevalence: Cardiovascular disease is a leading cause of death for both men and women. ◦ Pathophysiology: Inflammation, obesity, type 2 diabetes, and metabolic syndrome play more prominent roles in coronary atherosclerosis in women than in men. ◦ Microcirculation: CAD is more frequently associated with dysfunction of the coronary microcirculation in women than in men. ◦ Diagnostic Accuracy: Exercise electrocardiography has a lower diagnostic accuracy in predicting epicardial obstruction in women than in men.

KEY PEARLS & CLINICAL TRAPS¶

• Symptom Timing: Exertional symptoms are hallmark indicators of heart disease; rest-only symptoms that improve with exercise are rare. ◦ Note: Some patients may be asymptomatic at both rest and during exertion but have abnormal physical findings (murmurs, high BP) or ECG/imaging abnormalities. • Murmur Rule: Most murmurs are midsystolic and soft (grades I–II/VI). • Risk Factor Management: Identifying risk factors in asymptomatic patients is critical to prevent catastrophic events like sudden death or stroke.

Reference Tables¶

TABLE 243-1 New York Heart Association Functional Classification Class I¶

Harrison's 22e, p.1842

Class I No limitation of physical activity No symptoms with ordinary exertion Class II Slight limitation of physical activity Ordinary activity causes symptoms	Class III Marked limitation of physical activity Less than ordinary activity causes symptoms Asymptomatic at rest Class IV Inability to carry out any physical activity without discomfort Symptoms at rest